Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide (NNC 90-1170) Phase 2 Dose-Titration Study in Type 2 Diabetes
NCT01511172Phase 2Completed
- Sponsor
- Novo Nordisk
- Start
- Aug 2002
- Primary completion
- Dec 2002
- Modality
- Peptides
- Countries
- 8
01
Overview
A Phase 2 trial of liraglutide in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Aug 2002; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01511172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01511172.